UNICEF Tender Announcement: August 2024

UNICEF, the United Nations Children’s Fund, is set to release a tender for the procurement of critical antihelminthic medications in August 2024. This tender is part of UNICEF’s ongoing efforts to combat parasitic infections in children and vulnerable populations worldwide. The tender will cover the following three essential products:

1. Mebendazole 500mg Tablets
2. Albendazole 400mg Tablets
3. Praziquantel 600mg Tablets

These medications play a vital role in treating various helminth infections, which are caused by parasitic worms. Such infections are prevalent in many developing regions and can lead to severe health issues, especially in children. By addressing these infections, UNICEF aims to improve the health and quality of life for millions of affected individuals.

Product Details

1. Mebendazole 500mg Tablets:
• Usage: Mebendazole is used to treat infections caused by various types of worms, including pinworms, roundworms, and hookworms. It works by preventing the worms from absorbing sugar, which depletes their energy and eventually kills them.
• Dosage: Typically administered as a single dose or over several days, depending on the type of infection.

2. Albendazole 400mg Tablets:
• Usage: Albendazole is effective against a broad spectrum of parasitic worms. It is commonly used to treat infections such as ascariasis, trichuriasis, and hookworm. Albendazole works by disrupting the energy production of the parasites.
• Dosage: Often given as a single dose or in a series of doses over a few days.

3. Praziquantel 600mg Tablets:
• Usage: Praziquantel is primarily used to treat schistosomiasis and liver fluke infections. It increases the permeability of the parasite’s cell membranes, causing paralysis and death of the worms.
• Dosage: Typically administered based on body weight, usually as a single dose or divided doses over a day.

Call to Action for Suppliers:

UNICEF invites pharmaceutical manufacturers and suppliers to prepare for the upcoming tender. Companies with the capability to supply high-quality antihelminthic medications are encouraged to participate. This tender represents a significant opportunity to contribute to global health initiatives and support UNICEF’s mission to save and improve children’s lives.

Stay tuned for further updates and detailed tender documents, which will be released in August 2024. For more information, visit UNICEF’s official procurement website or contact the procurement department directly.

Note:

• FindmyCustomer offers strategic partnership support for Pharma business through its company “Amedra Healthcare.” For business inquiries, please contact us at director@amedra.in
• To receive notification of such exclusive high value pharma leads at no cost, share this lead on your social media and tag us.